v3.24.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
ASSETS    
Cash $ 5,913,215 $ 2,401,831
Digital assets - current (Note 2) 3,983,800 3,416,256
Finance receivables 25,410 19,221
Marketable securities (Note 5) 18,844 17,860
Receivable from sale of Symbiont assets (Note 5) 200,000 200,000
Prepaid expenses and other assets 416,516 4,067,212
Income tax receivable 31,187 31,187
Current assets 11,300,812 10,153,567
Fixed assets, net (Note 3) 17,311,254 24,519,610
Deposits on mining equipment (Note 4) 20,847 20,837
Long-term investments - equity securities (Note 5) 8,944 156,992
Investment in Seastar Medical Holding Corporation (Note 5) $ 440,910 $ 1,145,486
Investment, Issuer Affiliation [Extensible Enumeration] us-gaap:InvestmentAffiliatedIssuerMember us-gaap:InvestmentAffiliatedIssuerMember
Digital assets - long-term (Note 2) $ 5,000,000  
Operating lease - right of use assets (Note 7) 109,380 $ 189,009
Other assets 73,857 86,798
Long-term assets 25,235,055 27,559,230
Total assets 36,535,867 37,712,797
Liabilities and stockholders' equity    
Accounts payable and accrued expenses 1,400,228 2,064,909
Note payable - short-term (Note 6) 1,520,564 567,586
Due to related parties (Note 10) $ 64,386 $ 22,845
Other Liability, Current, Related Party [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of lease liability (Note 7) $ 109,931 $ 110,384
Total current liabilities 3,095,109 2,765,724
Note payable - long-term (Note 6) 4,844,084  
Lease liability - net of current portion (Note 7) 4,924 85,775
Long-term liabilities 4,849,008 85,775
Total liabilities 7,944,117 2,851,499
Stockholders' equity (Note 8)    
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of September 30, 2024 and December 31, 2023
Common stock, par value $.001; 350,000,000 shares authorized; 2,956,042 shares issued and outstanding as of September 30, 2024 and 2,492,964 as of December 31, 2023 2,822 2,493
Additional paid-in capital 97,827,489 95,145,376
Accumulated deficit (67,628,539) (58,961,461)
Total LM Funding America stockholders' equity 30,201,772 36,186,408
Non-controlling interest (1,610,022) (1,325,110)
Total stockholders’ equity 28,591,750 34,861,298
Total liabilities and stockholders’ equity 36,535,867 37,712,797
Seastar Medical [Member]    
ASSETS    
Notes receivable net of current portion   $ 1,440,498
Tech Infrastructure JV I LLC [Member]    
ASSETS    
Current portion of notes receivable 711,840  
Notes receivable net of current portion $ 2,269,863  

Source

HTML PDF
ZIP